valine and efavirenz

valine has been researched along with efavirenz in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Franklin, AM; Jorgensen, WL; Rader, LH; Smith, KD; Smith, MB; Smith, RH; Taylor, EV; Tirado-Rives, J	1
Shah, I	1
Bertz, R; Bifano, M; Grasela, D; Hartstra, J; Hwang, C; Kandoussi, H; Oosterhuis, B; Sevinsky, H; Tiessen, R; Velinova-Donga, M	1

Trials

1 trial(s) available for valine and efavirenz

Article	Year
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir. Antiviral therapy, 2013, Volume: 18, Issue:7 Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Pyrrolidines; Ritonavir; Tenofovir; Valine; Viral Nonstructural Proteins; Young Adult	2013

Article

Year

Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.

Antiviral therapy, 2013, Volume: 18, Issue:7

Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Pyrrolidines; Ritonavir; Tenofovir; Valine; Viral Nonstructural Proteins; Young Adult

2013

Other Studies

2 other study(ies) available for valine and efavirenz

Article	Year
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz. Bioorganic & medicinal chemistry letters, 2008, Feb-01, Volume: 18, Issue:3 Topics: Alkynes; Amino Acid Substitution; Anti-HIV Agents; Benzoxazines; Computer Simulation; Cyclopropanes; Drug Resistance; Drug Resistance, Viral; HIV Reverse Transcriptase; Humans; Leucine; Models, Molecular; Molecular Structure; Mutation, Missense; Nevirapine; Reverse Transcriptase Inhibitors; Thermodynamics; Tyrosine; Valine	2008
Response to valacyclovir in an HIV-infected girl with Epstein Barr infection. Indian pediatrics, 2012, Volume: 49, Issue:5 Topics: Acyclovir; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Child; Cyclopropanes; Epstein-Barr Virus Infections; Female; HIV Infections; Humans; Lamivudine; Valacyclovir; Valine; Zidovudine	2012

Article

Year

Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz.

Bioorganic & medicinal chemistry letters, 2008, Feb-01, Volume: 18, Issue:3

Topics: Alkynes; Amino Acid Substitution; Anti-HIV Agents; Benzoxazines; Computer Simulation; Cyclopropanes; Drug Resistance; Drug Resistance, Viral; HIV Reverse Transcriptase; Humans; Leucine; Models, Molecular; Molecular Structure; Mutation, Missense; Nevirapine; Reverse Transcriptase Inhibitors; Thermodynamics; Tyrosine; Valine

2008

Response to valacyclovir in an HIV-infected girl with Epstein Barr infection.

Indian pediatrics, 2012, Volume: 49, Issue:5

Topics: Acyclovir; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Child; Cyclopropanes; Epstein-Barr Virus Infections; Female; HIV Infections; Humans; Lamivudine; Valacyclovir; Valine; Zidovudine

2012